Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
opioid, Journavx and FDA
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
FDA approves new, non-opioid painkiller Journavx
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.
FDA approves 1st new class of opioid-free painkillers in over 20 years
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
FDA Approves First New Non-Opioid Pain Pill in Decades
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
What is Non-Opioid Pain Medication? Journavx Approved by FDA
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA).
Vertex Pharmaceuticals Shares Gain After FDA Approves Non-Opioid Pain Drug
Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug Administration approval.
2h
on MSN
EssilorLuxottica receives FDA clearance for its Nuance audio glasses
EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its ...
13h
FDA escalates Walmart broccoli recall to highest threat level: Risk of 'death'
Some packages of Walmart-sold broccoli florets have been recalled by its manufacturer. The FDA has designated the recall as a ...
Hosted on MSN
2d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to know
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
Food Safety News
5h
FDA warns seafood companies over HACCP violations and potentially adulterated products
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...
FOX 10 Phoenix
13h
FDA recalls breadcrumbs sold nationwide
The unseasoned bread crumbs were sold at stores throughout the United States from April 10, 2024, through Jan. 22, 2025, said ...
2d
Chocolate recall elevated to highest risk level by FDA due to risk of 'adverse health consequences’
A major chocolate recall has been upgraded to the highest possible risk level.
13h
on MSN
FDA classifies Lay’s recall as Class 1 due to undeclared milk allergen
Last month, a recall was issued for Lay’s Classic Potato Chips sold in Oregon and Washington due to the potential presence of ...
Targeted Oncology
21h
The Targeted Pulse: Sniffing out the Latest From ASCO GI 2025 and Fresh FDA Activity
Aspirin reduced recurrence by 50% in PIK3CA-mutated colorectal cancer, the DCISionRT test earned FDA breakthrough status for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Trump
United States
recall
Journavx
Super Bowl
Feedback